Topical cyclosporin A 2% in the treatment of vernal keratoconjunctivitis

Eye

Volumn 11, Issue 1, 1997, Pages 75-78

  Mendicute, Javier ^a,b   Aranzasti, C ^a   Eder, F ^a   Ostolaza, J I ^a   Salaberria, M ^a  

^a Hospital de Guipuzcoa   (Spain)

^b Azara 17 1 E ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; EYE DROPS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HUMAN; KERATOCONJUNCTIVITIS; MALE; SCHOOL CHILD; TOPICAL DRUG ADMINISTRATION; VERNAL CONJUNCTIVITIS;

EID: 0030902134     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1997.14     Document Type: Article

References (6)

1. BenEzra D, Pe'er J, Brodsky M, Cohen E. Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol 1986;101:278.
2. BenEzra D, Matamoros N, Cohen E. Treatment of severe vernal karatoconjunctivitis with cyclosporine A eyedrops. Transplant Proc 1988;22(2)(Suppl 2):644-9.
3. Secchi A, Tognon S, Leonardi A. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol 1990;110:641-5.
4. Bleik J, Tabbara K. Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology 1991;98:1679-84.
5. Holland E, Olsen T, Ketcham J, Florine C, Krachmer J, Purcell J, et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea 1993;12:413-9.
6. Kaan G, Özden Ö. Therapeutic use of topical cyclosporine. Ann Ophthalmol 1993;25:182-6.